ATAI – ataibeckley inc. (US:NASDAQ)
Stock Stats
News
BPL-003 Demonstrates Rapid and Durable Antidepressant Effects in Treatment-Resistant Depression; Phase 2a Data Published in Journal of Psychopharmacology; Phase 3 Program on Track for Q2 2026 Initiation
BPL-003 Phase 3 Program Initiation on Track for Q2 2026 Following Successful FDA End-of-Phase 2 Meeting; AtaiBeckley Highlights Key Pipeline Milestones at 2026 Investor Day
CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions
AtaiBeckley (ATAI) Reports 2025 Results and Q2 2026 Phase 3 Launch for BPL-003 [Yahoo! Finance]
AtaiBeckley reports 2025 results as it eyes Q2 start for Phase 3 depression trial [Yahoo! Finance]
Form 4 AtaiBeckley Inc. For: Mar 11 Filed by: Faerm Michael E.
Form 3 AtaiBeckley Inc. For: Mar 09 Filed by: Faerm Michael E.
Form 144 Atai Beckley N.V. Filed by: Feilding-Mellen Cosmo
Form 4 AtaiBeckley Inc. For: Jan 30 Filed by: Rao Srinivas
Form 4 AtaiBeckley Inc. For: Jan 30 Filed by: Barrett Christopher Ryan Cave
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.